Correction to: Blood Cancer Journal https://doi.org/10.1038/s41408-022-00739-w, published online 04 October 2022
In this article, Acknowledgements section was incorrectly given. It should have read as below.
This work was supported in part by National Institutes of Health, National Heart, Lung, and Blood Institute grant R01 HL141336, R01 CA248149, a Research Scholar grant (RSG-19-036-01-LIB) from the American Cancer Society, the Gehr Family Center for Leukemia Research (LL) and the Vera and Joseph Dresner Foundation for established investigator award (LL and GM).
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Huang, F., Sun, J., Chen, W. et al. Correction: TET2 deficiency promotes MDS-associated leukemogenesis. Blood Cancer J. 13, 174 (2023). https://doi.org/10.1038/s41408-023-00952-1
Published:
DOI: https://doi.org/10.1038/s41408-023-00952-1
